CY1105106T1 - Συνδυασμος ενος αντιθρομβωτικου και ασπιρινης και η χρηση τους για την θεραπεια θρομβωτικων και αρτηριοσκληρωτικων ασθενειων - Google Patents

Συνδυασμος ενος αντιθρομβωτικου και ασπιρινης και η χρηση τους για την θεραπεια θρομβωτικων και αρτηριοσκληρωτικων ασθενειων

Info

Publication number
CY1105106T1
CY1105106T1 CY20061101027T CY061101027T CY1105106T1 CY 1105106 T1 CY1105106 T1 CY 1105106T1 CY 20061101027 T CY20061101027 T CY 20061101027T CY 061101027 T CY061101027 T CY 061101027T CY 1105106 T1 CY1105106 T1 CY 1105106T1
Authority
CY
Cyprus
Prior art keywords
aspirin
arterosclerous
thrombotic
diseases
combination
Prior art date
Application number
CY20061101027T
Other languages
Greek (el)
English (en)
Inventor
Tony Verbeuren
Gilbert Lavielle
Bernard Cimetiere
Marie-Odile Vallez
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of CY1105106T1 publication Critical patent/CY1105106T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY20061101027T 2002-04-05 2006-07-24 Συνδυασμος ενος αντιθρομβωτικου και ασπιρινης και η χρηση τους για την θεραπεια θρομβωτικων και αρτηριοσκληρωτικων ασθενειων CY1105106T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine
PCT/FR2003/001054 WO2003084525A1 (fr) 2002-04-05 2003-04-04 Nouvelle association d'un antithrombotique et d'aspirine

Publications (1)

Publication Number Publication Date
CY1105106T1 true CY1105106T1 (el) 2009-11-04

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101027T CY1105106T1 (el) 2002-04-05 2006-07-24 Συνδυασμος ενος αντιθρομβωτικου και ασπιρινης και η χρηση τους για την θεραπεια θρομβωτικων και αρτηριοσκληρωτικων ασθενειων

Country Status (26)

Country Link
US (1) US7618955B2 (cg-RX-API-DMAC7.html)
EP (1) EP1496884B1 (cg-RX-API-DMAC7.html)
JP (1) JP4065853B2 (cg-RX-API-DMAC7.html)
KR (1) KR100645143B1 (cg-RX-API-DMAC7.html)
CN (1) CN1297265C (cg-RX-API-DMAC7.html)
AR (1) AR039253A1 (cg-RX-API-DMAC7.html)
AT (1) ATE329591T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003246774B2 (cg-RX-API-DMAC7.html)
BR (1) BR0309019A (cg-RX-API-DMAC7.html)
CA (1) CA2480697A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105106T1 (cg-RX-API-DMAC7.html)
DE (1) DE60306133T2 (cg-RX-API-DMAC7.html)
DK (1) DK1496884T3 (cg-RX-API-DMAC7.html)
EA (1) EA006978B1 (cg-RX-API-DMAC7.html)
ES (1) ES2264533T3 (cg-RX-API-DMAC7.html)
FR (1) FR2838057B1 (cg-RX-API-DMAC7.html)
GE (1) GEP20074101B (cg-RX-API-DMAC7.html)
MA (1) MA27114A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04009760A (cg-RX-API-DMAC7.html)
NO (1) NO20044700L (cg-RX-API-DMAC7.html)
NZ (1) NZ535430A (cg-RX-API-DMAC7.html)
PL (1) PL371620A1 (cg-RX-API-DMAC7.html)
PT (1) PT1496884E (cg-RX-API-DMAC7.html)
UA (1) UA79457C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003084525A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200407593B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2376994C2 (ru) * 2005-07-22 2009-12-27 Дзе Проктер Энд Гэмбл Компани Составы для снижения риска возникновения вызванной лекарственными средствами аритмии
EP2155195B1 (en) 2007-04-13 2014-07-16 Millennium Pharmaceuticals, Inc. Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
NO20044700L (no) 2004-10-29
MA27114A1 (fr) 2004-12-20
NZ535430A (en) 2006-09-29
CN1297265C (zh) 2007-01-31
AU2003246774B2 (en) 2007-02-15
US7618955B2 (en) 2009-11-17
GEP20074101B (en) 2007-05-10
DE60306133D1 (de) 2006-07-27
KR100645143B1 (ko) 2006-11-10
AR039253A1 (es) 2005-02-16
WO2003084525A1 (fr) 2003-10-16
FR2838057A1 (fr) 2003-10-10
CN1646111A (zh) 2005-07-27
HK1076034A1 (en) 2006-01-06
AU2003246774A1 (en) 2003-10-20
EP1496884A1 (fr) 2005-01-19
ES2264533T3 (es) 2007-01-01
KR20040098053A (ko) 2004-11-18
EA200401293A1 (ru) 2005-02-24
EA006978B1 (ru) 2006-06-30
JP2005528376A (ja) 2005-09-22
CA2480697A1 (fr) 2003-10-16
US20050143354A1 (en) 2005-06-30
ZA200407593B (en) 2006-07-26
UA79457C2 (en) 2007-06-25
MXPA04009760A (es) 2004-12-13
EP1496884B1 (fr) 2006-06-14
DE60306133T2 (de) 2007-01-04
FR2838057B1 (fr) 2005-07-08
ATE329591T1 (de) 2006-07-15
PL371620A1 (en) 2005-06-27
DK1496884T3 (da) 2006-10-02
JP4065853B2 (ja) 2008-03-26
BR0309019A (pt) 2005-02-01
PT1496884E (pt) 2006-09-29

Similar Documents

Publication Publication Date Title
CY1109422T1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
CY1113306T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
CY1110271T1 (el) Υδατικες παρατεταμενης-απελευθερωσης φαρμακοτεχνικες μορφες πρωτεϊνων
CY1113105T1 (el) Παραγωγα ξανθινης, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
ATE365720T1 (de) Agonisten von beta-adrenorezeptoren
MX9800348A (es) Inhibidores de adhesion celular.
CY1106602T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
CY1111613T1 (el) Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
CY1108578T1 (el) Φαρμακευτικες συνθεσεις (κιτ) περιλαμβανοντας ενωσεις διϋδροπυριδινονης και εναν ανοσορυθμιστικο (ή εναν αντιφλεγμονωδη) παραγοντα και οι χρησεις αυτων
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
CY1114616T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
CY1107440T1 (el) Ενωσεις αρυλουριας εν συνδυασμω με αλλα κυτταροστατικα ή κυτταροτοξικα μεσα για τη θεραπεια ανθρωπινων καρκινων
SE0301700D0 (sv) Novel compounds
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
ATE408601T1 (de) Fredericamycin-derivate
CY1109013T1 (el) Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1110600T1 (el) Αναλογα της βιταμινης d
PT1082321E (pt) Derivados heterociclicos que inibem o factor xa
SE0203825D0 (sv) Novel fused heterocycles and uses thereof